BioFlyte® is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats.
Their instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to safety and security.
BioFlyte’s products are designed to autonomously sample ambient air, for example, in critical infrastructure, but can also accept liquid or powder samples manually.
BioTOF™ z200 – A Comprehensive Bio-Threat Solution for Critical Infrastructure
BioCapture™ z720 – Handheld Air Sampler for SARS-CoV-2 Detection
BioCapture™ z750 – Handheld Air Sampler for CBRN Defense Forces and Emergency Response Teams
BioFlyte Welcomes New CEO to Drive Commercialization Efforts
BioFlyte Raises $6.1M in Series A Financing to Advance Biothreat Detection Technology
Startup BioFlyte Detects Airborne SARS-CoV-2 Using BioFire FilmArray
BioFlyte Forms Scientific Advisory Board of Prominent Government and Life Science Experts